Loading clinical trials...
Loading clinical trials...
A Post Authorization Study, Designed to Learn More About the Safety and Efficacy of the Use of VELCADE (Bortezomib) in the Netherlands
Conditions
Interventions
bortezomib
Locations
44
Netherlands
's-Hertogenbosch, Netherlands
Alkmaar, Netherlands
Amersfoort, Netherlands
Amstelveen, Netherlands
Amsterdam-Zuidoost, Netherlands
Apeldoorn, Netherlands
Start Date
November 1, 2004
Primary Completion Date
January 1, 2012
Completion Date
January 1, 2012
Last Updated
January 14, 2014
NCT06152575
NCT06179888
NCT04973605
NCT05201781
NCT06138275
NCT05862012
Lead Sponsor
Janssen-Cilag B.V.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions